Equities

Benchmark Holdings PLC

BMK:LSE

Benchmark Holdings PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)45.00
  • Today's Change-0.50 / -1.10%
  • Shares traded126.76k
  • 1 Year change12.50%
  • Beta0.9499
Data delayed at least 20 minutes, as of May 03 2024 14:54 BST.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 02-May-24
Select bar for recommendation details.
Recommendations02-May-24
Buy0
Outperform1
Hold1
Underperform0
Sell0

Share price forecast

The 2 analysts offering 12 month price targets for Benchmark Holdings PLC have a median target of 46.33, with a high estimate of 50.66 and a low estimate of 42.00. The median estimate represents a 2.96% increase from the last price of 45.00.
High12.6%50.66
Med3.0%46.33
Low-6.7%42.00

Earnings history & estimates

Benchmark Holdings PLC reported annual 2023 losses of -2.09 per share on Nov 29, 2023.
Average growth rate-16.64%
More ▼

Revenue history & estimates

Benchmark Holdings plc had revenues for the full year 2023 of 169.74m. This was 7.24% above the prior year's results.
Average growth rate+5.81%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.